Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice. Transplantation 2004;77(7):990. [PubMed: 15087759]Makhlouf L,Grey ST,Dong V,et al.Depleting anti-CD4 monoclonal antibody cures new-...
PE/Dazzle™ 594 anti-mouse CD4 Antibody - CD4 is a 55 kD protein also known as L3T4 or T4.
The CD4 antigen functions as a co-receptor, interacting with class II major histocompatability complex (MHC) molecules in the recognition of foreign antigens by T cells. In vivo and in vitro treatment with the GK1.5 monoclonal antibody effectively depletes CD4+ cells. GK1.5 also blocks helper...
Alexa Fluor® 594 anti-mouse CD4 Antibody - CD4 is a 55 kD protein also known as L3T4 or T4.
Mouse CD4+ T cellin vivodepletion using Anti-mCD4-mIgG2a InvivoFit™ has been confirmed The complete sequence of the antibody construct has been verified < 5% aggregates (confirmed by size exclusion chromatography) Endotoxin level <1 EU/mg (determined by the LAL assay) ...
Recombinant Anti-CD3 antibody (Rabbit mAb) 100 μL ¥1650 加入购物车 GB151137-50 Recombinant Anti-CD3 antibody (Rabbit mAb) 50 μL ¥950 加入购物车 GB15064-100 Recombinant Anti-CD4 antibody (Rabbit mAb) 100 μL ¥1650 加入购物车 ...
CD_antigen: CD4; CD4 antigen (p55); CD4 antigen; CD4 molecule; CD4 receptor; CD4; CD4mut; T-cell surface antigen T4/Leu-3; T-cell surface glycoprotein CD4 Product Datasheets Product Datasheet COA SDS Related Research Areas Conventional/Classical Dendritic Cells ...
Additional reported applications (for the relevant formats) include: depletion of platelets and functional assay in vivo.^4,7 The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for in vivo studies (Cat. No. 133939).; ...
Compensation controls were prepared using 0.5 µg ml−1 of each antibody with UltraComp eBeads (Thermo Fisher Scientific). After staining, cells were washed, fixed (2% formaldehyde), washed and subjected to flow cytometric analysis. Dendritic and CD4+ T cell subpopulations were subjected ...
antibody to measure IFNγ production. The percentage of CD3+T cells, the proportion of CD4+, CD8+and Treg subsets and the level of IFNγ production was heterogeneous between tumor samples (Fig.4a). Treatment with MCLA-145 increased IFNγ production in all tumor samples relative to control ...